ResearcherShenyang Pharmaceutical UniversityNo recent work listed

Yueying Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-3710-0951; OpenAlex author ID A5110595680. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper

Papers 1

Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming. Co-author DOI 10.1007/s00109-022-02181-8 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hua Li · 1 shared paper, 2022 · strength 0.16
- Paper Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism r… DOI 10.1007/s00109-022-02181-8 ↗
Lixia Chen · 1 shared paper, 2022 · strength 0.16
- Paper Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism r… DOI 10.1007/s00109-022-02181-8 ↗
Mengzhu Zheng · 1 shared paper, 2022 · strength 0.16
- Paper Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism r… DOI 10.1007/s00109-022-02181-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.